Quantcast

Latest Management of cancer Stories

2014-07-16 23:10:21

For the first time ever, Prostate cancer patients can complete a survey describing how their diagnosis changed their lives. New York, NY (PRWEB) July 16, 2014 Prostate cancer disrupts men's lives in ways that are unimaginable. Now, for the first time ever, a national survey is asking men to describe their experiences regarding life after Prostate Cancer diagnosis. The National Men's Cancer Survivor support and advocacy nonprofit, Malecare Cancer Support, designed and launched...

2014-07-15 12:29:13

This collaboration complements world-class cancer care with sophisticated scientific research focused on providing targeted therapies DANVILLE, Pa. and HAMBURG, Germany, July 15, 2014 /PRNewswire-USNewswire/ -- Indivumed, a leading provider of services enabling individualized cancer therapy, and Geisinger Health System (Geisinger), one of the largest integrated health systems in the United States serving approximately 3 million people, today announced a partnership that will afford...

First Antibodies To Treat Cancer In Dogs Developed
2014-07-07 03:10:21

University of Veterinary Medicine Vienna Nearly every second dog develops cancer from the age of ten years onward. A few therapies derived from human medicine are available for dogs. A very successful form of therapy by which antibodies inhibit tumor growth has not been available for animals so far. Scientists at the inter-university Messerli Research Institute of the Vetmeduni Vienna, the Medical University of Vienna, and the University of Vienna have developed, for the first time,...

2014-07-02 16:24:28

In this phase two study, 50 percent of glioblastoma patients lived for two years, an encouraging result for one of the most deadly cancers that often kills patients within one year of diagnosis CHICAGO, July 2, 2014 /PRNewswire-USNewswire/ -- Patients newly diagnosed with glioblastoma multiforme (GBM) and treated with an experimental cancer vaccine made from the patient's own tumor in addition to standard of care lived longer compared to those who received standard of care alone,...

2014-07-01 10:07:43

University of Pennsylvania School of Medicine Lack of clinical trial data, guidelines on HIV patients with cancer may contribute to health disparity HIV-infected people diagnosed with cancer are two to four times more likely to go untreated for their cancer compared to uninfected cancer patients, according to a new, large retrospective study from researchers in Penn Medicine's Abramson Cancer Center and the National Cancer Institute (NCI) published online ahead of print in the Journal...

2014-06-27 12:26:33

Study published in Clinical Cancer Research and co-led by Adaptive Biotechnologies and the University of Washington demonstrates clinical utility of Next Generation Immune Profiling SEATTLE, June 27, 2014 /PRNewswire/ -- Adaptive Biotechnologies today announced results demonstrating enhanced accuracy and sensitivity of clonoSEQ in identifying risk of relapse in patients with B-cell Acute Lymphoblastic Leukemia (B-ALL), a childhood leukemia, compared to flow cytometry, the current...

2014-06-24 23:03:05

New research report “Cancer Cell Therapy Market & Pipeline Insight” elaborated by Kuick Research is now available at MarketPublishers.com London, UK (PRWEB) June 24, 2014 Over the past 5 years, the world cancer cell therapy market witnessed strong growth. Furthermore, this market is expected to keep on following an upward trend in the years ahead, driven by the increasing cancer incidence worldwide, rising adoption of novel drugs, high unmet needs along with the continuously...

2014-06-24 08:31:08

U.S. Phase 2a Clinical Trial in Recurrent Glioblastoma to Initiate in Early 2015 SYDNEY, June 24, 2014 /PRNewswire/ -- EnGeneIC, Ltd., an emerging biopharmaceutical company focused on revolutionizing the treatment of cancer through the targeted delivery of therapeutic agents directly to cancer cells, today announced plans to move forward with a Phase 2a clinical trial in the U.S. using its formulation of EGFR-targeted, EDV(TM) nanocells packaged with doxorubicin for the treatment...

2014-06-24 08:30:24

Using CyberKnife and chemotherapy, doctors treat primary and metastatic tumors FENTON, Mo., June 24, 2014 /PRNewswire/ -- When St. Louis CyberKnife patient Theresa Thompson was diagnosed with stage IV lung cancer, doctors determined the disease had spread beyond her lungs to her brain. http://photos.prnewswire.com/prnvar/20140623/120686 While stage IV lung cancer is difficult to treat, doctors reviewed her case and decided to aggressively treat with CyberKnife and chemotherapy....

2014-06-24 08:29:35

Yet Canadians in the dark about cancer survival rates OTTAWA, June 24, 2014 /CNW/ - Cancer isn't always a matter of life and death anymore - today, an increasing number of Canadians are living with cancer as a chronic condition. However, the majority of Canadians and the healthcare system have not necessarily responded to this shift. "The fact is, 63 per cent of Canadian cancer patients live longer than five years after diagnosis(i), and if a cancer patient survives past one year,...


Word of the Day
cenobite
  • One of a religious order living in a convent or in community; a monk: opposed to anchoret or hermit (one who lives in solitude).
  • A social bee.
This word comes from the Latin 'coenobium,' convent, which comes from the Greek 'koinobios,' living in community.
Related